Guirguis, A., Chiappini, S., Vickers-Smith, R., Harris, D., Pelletier, G. D. P., Corkery, J. M., . . . Schifano, F. (2023). Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. Pharmaceuticals, 16(7), p. 994. doi:10.3390/ph16070994

Guirguis, Amira, Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, G. Duccio Papanti Pelletier, John Martin Corkery, Giovanni Martinotti, Stefano L. Sensi, and Fabrizio Schifano. "Is There a Risk for Semaglutide Misuse? Focus On the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset." Pharmaceuticals 16, no. 7 (2023): 994.

Guirguis, Amira, et al. "Is There a Risk for Semaglutide Misuse? Focus On the Food and Drug Administration’s FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset." Pharmaceuticals 16.7 (2023): 994.